Renewable Chemicals & Biobased Materials

The successful construction of a synthesized genome could enable new research and development of human therapies, biofuels, and biobased chemicals from renewable resources.

The keys to successful industrial biotech business relationships mirror those for successful personal relationships, industry leaders explained today.  During the final Lunch Plenary Session of BIO’s 2011 World Congress in Toronto, moderator James Stoppert, CEO of BioAdvisors, along with panelists Patrick Gruber, CEO of Gevo, Ron Commander, Head of Butyl Rubber Business Unit at Lanxess, Christophe Schilling, CEO of Genomatica, and Hisao Urata, General Manager of Corporate Planning at Mitsubishi Chemical discussed “Strategic Partnerships for More Robust Value Chains” and identified some key components to that end.

During today’s plenary lunch session at BIO's 2011 World Congress in Toronto, Royal DSM CEO Feike Sijbesma gave a passionate keynote address and accepted the 2011 George Washington Carver Award for his company’s efforts to promote bio-based products over those relying on fossil-fuel resources.

"The Value Proposition for Cellulosic and Advanced Biofuels Under the Federal Renewable Fuel Standard" is forthcoming in the April 2011 Industrial Biotechnology Journal.

Upward trends and investment opportunities will be focus of BIO’s World Congress in May.

Industry leaders point out that biotech-enabled advanced biofuels spur job growth and reduce U.S. dependence on imported oil.

BIO review of this emerging science illustrates progress in applying synthetic biology to improve manufacturing processes.